{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:19:44Z","timestamp":1767925184648,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To evaluate the safety and effectiveness of different dosages of intranasal Dexmedetomidine (DEX) in combination with oral midazolam for sedation of young children during brain MRI examination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Included in this prospective single-blind randomized controlled trial were 156 children aged from 3 months to 6 years and weighing from 4 to 20 Kg with ASA I-II who underwent brain MRI examination between March 2021 and February 2022. Using the random number table method, they were divided into group A (using 3 ug\/kg intranasal DEX plus 0.2 mg\/Kg oral midazolam) and group B (using 2 ug\/kg intranasal DEX plus 0.2 mg\/Kg oral Midazolam). The one-time success rate of sedation, sedation onset time, recovery time, overall sedation time, and occurrence of adverse reactions during MRI examination were compared between the two groups. The heart rate (HR), mean arterial pressure (MAP), and percutaneous SpO<jats:sub>2<\/jats:sub>before and after drug administration were observed in both groups. Differences in sedation scores between the two groups were compared before intranasal drug administration (T0), 10 min after drug administration (T1), at the time of falling asleep (T2), at the end of examination (T3), and at the time of recovery (T4).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The one-time success rate of sedation in group A and B was 88.31% and 79.75% respectively, showing no significant difference between the two groups (<jats:italic>P<\/jats:italic>&gt;0.05). The sedation onset time in group A was 24.97\u00b116.94 min versus 27.92\u00b115.83 min in group B, and the recovery time was 61.88\u00b122.18 min versus 61.16\u00b128.16 min, both showing no significance difference between the two groups (<jats:italic>P<\/jats:italic>&gt;0.05). Children in both groups exhibited good drug tolerance without presenting nausea and vomiting, hypoxia, or bradycardia and hypotension that needed clinical interventions. There was no significant difference in the occurrence of abnormal HR, MAP or other adverse reactions between the two groups (<jats:italic>P<\/jats:italic>&gt;0.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>3 ug\/kg or 2 ug\/kg intranasal DEX in combination with 0.2 mg\/kg oral Midazolam both are safe and effective for sedation of children undergoing MRI examination with the advantages of fast-acting and easy application.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>It was registered at the Chinese Clinical Trial Registry (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/searchproj.aspx?title=&amp;officialname=&amp;subjectid=&amp;secondaryid=&amp;applier=&amp;studyleader=\u00f0icalcommitteesanction=&amp;sponsor=&amp;studyailment=&amp;studyailmentcode=&amp;studytype=0&amp;studystage=0&amp;studydesign=0&amp;min\">ChiCTR1800015038<\/jats:ext-link>) on 02\/03\/2018.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-022-01897-x","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:07:07Z","timestamp":1669309627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Combined use of intranasal Dexmedetomidine and an oral novel formulation of Midazolam for sedation of young children during brain MRI examination: a prospective, single-center, randomized controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Hongbin","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guolin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denggui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"issue":"11","key":"1897_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14763","volume":"75","author":"D Karasu","year":"2021","unstructured":"Karasu D, et al. The frequency of emergence delirium in children undergoing outpatient anaesthesia for magnetic resonance imaging. Int J Clin Pract. 2021;75(11):e14763.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"1897_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00228-020-03028-2","volume":"77","author":"CE van Hoorn","year":"2021","unstructured":"van Hoorn CE, et al. Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists. Eur J Clin Pharmacol. 2021;77(4):625\u201335.","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"1897_CR3","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1111\/apa.15348","volume":"109","author":"M Tervonen","year":"2020","unstructured":"Tervonen M, et al. Systematic review and meta-analysis found that intranasal dexmedetomidine was a safe and effective sedative drug during paediatric procedural sedation. Acta Paediatr. 2020;109(10):2008\u201316.","journal-title":"Acta Paediatr"},{"issue":"10","key":"1897_CR4","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/pharmaceutics14102062","volume":"14","author":"M Zadrazil","year":"2022","unstructured":"Zadrazil M, et al. ADV6209 for Premedication in Pediatric Anesthesia: A Double-Blinded, Randomized Controlled Trial. Pharmaceutics. 2022;14(10):2062.","journal-title":"Pharmaceutics"},{"issue":"12","key":"1897_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/anae.14318","volume":"73","author":"S Salman","year":"2018","unstructured":"Salman S, et al. A novel, palatable paediatric oral formulation of midazolam: pharmacokinetics, tolerability, efficacy and safety. Anaesthesia. 2018;73(12):1469\u201377.","journal-title":"Anaesthesia"},{"issue":"9","key":"1897_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.echo.2014.04.024","volume":"27","author":"KW Stern","year":"2014","unstructured":"Stern KW, et al. The impact of procedural sedation on diagnostic errors in pediatric echocardiography. J Am Soc Echocardiogr. 2014;27(9):949\u201355.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"1897_CR7","first-page":"72","volume":"23","author":"JL Miller","year":"2018","unstructured":"Miller JL, et al. Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair. J Pediatr Pharmacol Ther. 2018;23(2):72\u201383.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"4","key":"1897_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jpeds.2013.05.010","volume":"163","author":"E Mekitarian Filho","year":"2013","unstructured":"Mekitarian Filho E, et al. Aerosolized intranasal midazolam for safe and effective sedation for quality computed tomography imaging in infants and children. J Pediatr. 2013;163(4):1217\u20139.","journal-title":"J Pediatr"},{"issue":"7","key":"1897_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/archdischild-2021-322734","volume":"107","author":"TJ Jackson","year":"2022","unstructured":"Jackson TJ, et al. Dexmedetomidine improves success of paediatric MRI sedation. Arch Dis Child. 2022;107(7):692\u20134.","journal-title":"Arch Dis Child"},{"issue":"3","key":"1897_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/ger.12262","volume":"34","author":"L Rignell","year":"2017","unstructured":"Rignell L, et al. Sedation with orally administered midazolam in elderly dental patients with major neurocognitive disorder. Gerodontology. 2017;34(3):299\u2013305.","journal-title":"Gerodontology"},{"issue":"2","key":"1897_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bja.2018.03.039","volume":"121","author":"HS Abdel-Ghaffar","year":"2018","unstructured":"Abdel-Ghaffar HS, et al. Comparison of nebulised dexmedetomidine, ketamine, or midazolam for premedication in preschool children undergoing bone marrow biopsy. Br J Anaesth. 2018;121(2):445\u201352.","journal-title":"Br J Anaesth"},{"key":"1897_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2020.109736","volume":"62","author":"Y Lin","year":"2020","unstructured":"Lin Y, et al. Dexmedetomidine versus other sedatives for non-painful pediatric examinations: A systematic review and meta-analysis of randomized controlled trials. J Clin Anesth. 2020;62:109736.","journal-title":"J Clin Anesth"},{"key":"1897_CR13","doi-asserted-by":"crossref","unstructured":"Poonai N, et al. Intranasal Dexmedetomidine for Procedural Distress in Children: A Systematic Review. Pediatrics. 2020;145(1).","DOI":"10.1542\/peds.2019-1623"},{"issue":"5","key":"1897_CR14","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/anae.13407","volume":"71","author":"BL Li","year":"2016","unstructured":"Li BL, et al. A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops. Anaesthesia. 2016;71(5):522\u20138.","journal-title":"Anaesthesia"},{"key":"1897_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.872900","volume":"10","author":"X Lyu","year":"2022","unstructured":"Lyu X, Tao Y, Dang X. Efficacy and Safety of Intranasal Dexmedetomidine vs. Oral Chloral Hydrate for Sedation in Children Undergoing Computed Tomography\/Magnetic Resonance Imaging: A Meta-Analysis. Front Pediatr. 2022;10:872900.","journal-title":"Front Pediatr"},{"key":"1897_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jclinane.2017.01.014","volume":"38","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, et al. The sedative effects of the intranasal administration of dexmedetomidine in children undergoing surgeries compared to other sedation methods: A systematic review and meta-analysis. J Clin Anesth. 2017;38:33\u20139.","journal-title":"J Clin Anesth"},{"issue":"1","key":"1897_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pan.13526","volume":"29","author":"F Yang","year":"2019","unstructured":"Yang F, et al. Analysis of 17 948 pediatric patients undergoing procedural sedation with a combination of intranasal dexmedetomidine and ketamine. Paediatr Anaesth. 2019;29(1):85\u201391.","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"1897_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13052-021-01196-0","volume":"48","author":"F Cossovel","year":"2022","unstructured":"Cossovel F, et al. Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam. Ital J Pediatr. 2022;48(1):5.","journal-title":"Ital J Pediatr"},{"issue":"5","key":"1897_CR19","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.annemergmed.2016.08.450","volume":"69","author":"DS Tsze","year":"2017","unstructured":"Tsze DS, et al. Optimal Volume of Administration of Intranasal Midazolam in Children: A Randomized Clinical Trial. Ann Emerg Med. 2017;69(5):600\u20139.","journal-title":"Ann Emerg Med"},{"issue":"9","key":"1897_CR20","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1007\/s10803-019-04095-w","volume":"49","author":"BL Li","year":"2019","unstructured":"Li BL, et al. A Comparison of Intranasal Dexmedetomidine and Dexmedetomidine Plus Buccal Midazolam for Non-painful Procedural Sedation in Children with Autism. J Autism Dev Disord. 2019;49(9):3798\u2013806.","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"1897_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/pan.13202","volume":"27","author":"G Cozzi","year":"2017","unstructured":"Cozzi G, et al. Combination of intranasal dexmedetomidine and oral midazolam as sedation for pediatric MRI. Paediatr Anaesth. 2017;27(9):976\u20137.","journal-title":"Paediatr Anaesth"},{"key":"1897_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.889369","volume":"10","author":"BL Li","year":"2022","unstructured":"Li BL, et al. Using intranasal dexmedetomidine with buccal midazolam for magnetic resonance imaging sedation in children: A single-arm prospective interventional study. Front Pediatr. 2022;10:889369.","journal-title":"Front Pediatr"},{"issue":"5","key":"1897_CR23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.bja.2018.01.035","volume":"120","author":"JW Miller","year":"2018","unstructured":"Miller JW, et al. Does intranasal dexmedetomidine provide adequate plasma concentrations for sedation in children: a pharmacokinetic study. Br J Anaesth. 2018;120(5):1056\u201365.","journal-title":"Br J Anaesth"},{"key":"1897_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2020.109746","volume":"63","author":"S Li","year":"2020","unstructured":"Li S, et al. The 95% effective dose of intranasal dexmedetomidine sedation for pulmonary function testing in children aged 1-3 years: A biased coin design up-and-down sequential method. J Clin Anesth. 2020;63:109746.","journal-title":"J Clin Anesth"},{"issue":"7","key":"1897_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s12630-016-0617-y","volume":"63","author":"JW Miller","year":"2016","unstructured":"Miller JW, et al. Dosing and efficacy of intranasal dexmedetomidine sedation for pediatric transthoracic echocardiography: a retrospective study. Can J Anaesth. 2016;63(7):834\u201341.","journal-title":"Can J Anaesth"},{"issue":"4","key":"1897_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/aas.13509","volume":"64","author":"H Lei","year":"2020","unstructured":"Lei H, et al. Incidence and risk factors of bradycardia in pediatric patients undergoing intranasal dexmedetomidine sedation. Acta Anaesthesiol Scand. 2020;64(4):464\u201371.","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01897-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01897-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:07:17Z","timestamp":1669309637000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01897-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1897"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01897-x","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Medical Ethics Committee of Shanghai Children\u2019s Medical Center(SCMCIRB-K20170690). All methods were carried out in accordance with relevant guidelines and regulations.Written informed consent to participate in this study was provided by the participant's legal guardian\/next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}